Management of no-reflow phenomenon in the catheterization laboratory
SH Rezkalla, RV Stankowski, J Hanna… - JACC: Cardiovascular …, 2017 - jacc.org
At the conclusion of a primary percutaneous coronary intervention for ST-segment elevation
myocardial infarction, and after the cardiologist makes certain that there is no residual …
myocardial infarction, and after the cardiologist makes certain that there is no residual …
Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy
G Ndrepepa, A Kastrati - Journal of Clinical Medicine, 2023 - mdpi.com
Coronary no-reflow (CNR) is a frequent phenomenon that develops in patients with ST-
segment elevation myocardial infarction (STEMI) following reperfusion therapy. CNR is …
segment elevation myocardial infarction (STEMI) following reperfusion therapy. CNR is …
No-reflow phenomenon in ST-segment elevation myocardial infarction: still the Achilles' heel of the interventionalist
Improvements in systems, technology and pharmacotherapy have significantly changed the
prognosis over recent decades in patients presenting with ST-segment elevation myocardial …
prognosis over recent decades in patients presenting with ST-segment elevation myocardial …
Predictive value of CHA2DS2-VASC score for contrast-induced nephropathy after percutaneous coronary intervention for acute coronary syndrome
A Kurtul, M Yarlioglues, M Duran - The American journal of cardiology, 2017 - Elsevier
The CHA2DS2-VASC score, used for embolic risk stratification in atrial fibrillation (AF), has
been reported recently to predict adverse clinical outcomes in patients with acute coronary …
been reported recently to predict adverse clinical outcomes in patients with acute coronary …
[HTML][HTML] CHA2DS2-VASc score predict no-reflow phenomenon in primary percutaneous coronary intervention in primary percutaneous coronary intervention
F Mirbolouk, M Gholipour, A Salari… - … of cardiovascular and …, 2018 - ncbi.nlm.nih.gov
Introduction: No-reflow is one of the major complications of primary PCI in patients with
acute ST elevation myocardial infarction. This phenomenon is associated with adverse …
acute ST elevation myocardial infarction. This phenomenon is associated with adverse …
The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction
This study was performed to evaluate the relationship between the CHA 2 DS 2-VASc score
and no-reflow (NR) phenomena in patients with non-ST-segment elevation myocardial …
and no-reflow (NR) phenomena in patients with non-ST-segment elevation myocardial …
Machine learning to predict no reflow and in-hospital mortality in patients with ST-segment elevation myocardial infarction that underwent primary percutaneous …
L Deng, X Zhao, X Su, M Zhou, D Huang… - BMC Medical Informatics …, 2022 - Springer
Background The machine learning algorithm (MLA) was implemented to establish an
optimal model to predict the no reflow (NR) process and in-hospital death that occurred in …
optimal model to predict the no reflow (NR) process and in-hospital death that occurred in …
New CHA2DS2-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation …
QY Zhang, SM Ma, JY Sun - BMC Cardiovascular Disorders, 2020 - Springer
Background The no-reflow phenomenon (NRP) is a serious complication of primary
percutaneous coronary intervention (PPCI) and is an independent predictor of poor …
percutaneous coronary intervention (PPCI) and is an independent predictor of poor …
[HTML][HTML] Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary …
Objectives The no-reflow phenomenon occurs in 25% of patients with ST elevation
myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) …
myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) …
CHA2DS2-VASc score as an independent predictor of suboptimal reperfusion and short-term mortality after primary PCI in patients with acute ST segment elevation …
A Ashoori, H Pourhosseini, S Ghodsi, M Salarifar… - Medicina, 2019 - mdpi.com
Background and objectives: We aimed to demonstrate the clinical utility of CHA2DS2-VASc
score in risk assessment of patients with STEMI regarding adverse clinical outcomes …
score in risk assessment of patients with STEMI regarding adverse clinical outcomes …